Clinical Trials Browser

Phase 2 × Pathologic Complete Response × tagraxofusp × Clear all

NCT07007052 2025-11-26

TAGVEN

Phase 2 Not yet recruiting

Pathologic Complete Response, Blastic Plasmacytoid Dendritic Cell Neoplasm